Sale

Cell Expansion Market

Global Cell Expansion Market Size, Share, Trends, Report: By Product: Consumables, Media, Reagent, SERA, Disposables, Instruments; By Cell Type: Human Cell, Animal Cell; By Application: Regenerative Medicine and Stem Cell Research, Cancer Research, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Cell Expansion Market Outlook

The global cell expansion market size was valued at USD 21 billion in 2023, driven by the rising incidence of chronic diseases and intensive research activities for cell-based therapies. The market is expected to grow at a CAGR of 16.2% during the forecast period of 2024-2032, with the values likely to reach USD 81 billion by 2032.

 

Global Cell Expansion Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cell Expansion Market Overview
 

The cell expansion market is experiencing significant growth and innovation, particularly in the fields of cell therapy, regenerative medicine, and biotechnology. Billions of therapeutic cells are usually needed for a single dose of cell therapy. Thus, cell culture and expansion form a critical step in the manufacturing as well as development of cell therapy, which has the potential to address the unmet medical needs of a growing population base. With cell-based therapies currently undergoing rapid development to treat chronic diseases such as cancer, diabetes, and neurodegenerative diseases, the cell expansion market demand is expected is witness a striking surge.

 

Key drivers of the market include the rise in geriatric population and the growing prevalence of chronic diseases. In the United States, heart disease is the most common cause of mortality followed by cancer. Further, it is estimated that 41 out of 100 men and 39 out of 100 women will develop cancer in their lifetime. The increased risk of developing cancer prompts the need for effective therapeutics, which is expected to accelerate the market growth of the cell expansion sector. In addition, intensive research activities directed at developing novel cell therapies will boost the market size. These research initiatives are increasingly supported by significant investments from private and public organizations, which will positively impact the market landscape.

 

The cell expansion market growth is also aided by the rising application of cell expansion protocols in regenerative medicine and stem cell research to counter the growing cancer cases. Technological advancements such as the automation of cell expansion processes will further augment the market share in the forecast period.

 

Intensive Research in Stem Cell Expansion

Robust research efforts in the field of cell expansion to support high manufacturing capacities have paved the way for rapid advancements. In May 2023, researchers from the University of Tokyo discovered a technique to scale up the number of human blood stem cells in the lab. The research, originally published in Nature, found that artificially boosting the PI3K phosphorylation mechanism can trigger the human blood stem cells or hematopoietic stem cells (HSCs) to expand successfully. The production of a large number of HSCs opens up new possibilities for medical therapies for treating leukemia and other blood disorders as well as for researchers studying blood stem function. This expanded scope of applications drives the need for cell expansion technologies, which may increase the cell expansion market share in the coming years.

 

Automation of Cell Expansion Protocols to Boost Market Value

Advances in cell expansion techniques and technologies including automation of cell expansion protocols are facilitating efficiency and scalability in cell manufacturing processes. These advancements will reduce production costs while improving the quality and consistency of cell-based products. Such developments are expected to expand the cell expansion market size in the coming years.

 

In January 2024, Multiply Labs (a United States-based robotics company that serves the pharmaceutical industry), in collaboration with Thermo Fisher Scientific, and Charles River, announced performance results for its proof-of-concept robotic system that aims at automating cell therapy manufacturing processes including cell quantity and quality. The data indicates that the new robotic technology can automate an existing cell expansion process without causing any significant protocol changes or affecting the quality of the final product. The integration of robotics not only minimizes bioprocess and regulatory risks but also speeds up the production of life-saving therapies.

 

Global Cell Expansion Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cell Expansion Market Segmentation

Market Breakup by Product

  • Consumables
    • Media
    • Reagent
    • SERA
    • Disposables
  • Instruments 
    • Cell Expansion Supporting Equipment
    • Bioreactors
    • Automated Cell Expansion Systems

 

Market Breakup by Cell Type

  • Human Cell
  • Animal Cell

 

Market Breakup by Application

  • Regenerative Medicine and Stem Cell Research
  • Cancer Research
  • Drug Screening and Development
  • Tissue Engineering
  • Other Applications

 

Market Breakup by End User

  • Biotechnology and Biopharmaceutical Companies
  • Research Institutes
  • Cell Banks
  • Other End User

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America

 

Global Cell Expansion Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cell Expansion Market Regional Analysis

In North America, the cell expansion sector is flourishing due to the rising investments by biotechnology companies to develop effective therapies including cell-based therapies. Another key driver is the increased strategic partnerships among the key market players to speed up the development of their products. In November 2023, a United States-based company 908 Devices Inc. known for its chemical and biochemical analysis products, and Terumo Blood and Cell Technologies (Terumo BCT) announced a collaboration initiative to provide on-line monitoring of Terumo BCT products. This collaboration integrates 908 Devices' MAVEN, an on-line glucose and lactate analyzer, into Terumo BCT's Quantum Flex platform. This advancement aims to accelerate cell and gene therapy development and manufacturing by providing real-time insights and control without manual sampling.

 

Europe also holds a substantial cell expansion market share, owing to the growing geriatric population and the prevalence of various diseases. Moreover, the dominance of the regional market can be attributed to the presence of leading market players and a well-established healthcare system that is actively supporting technological advancements in the segment.

 

Global Cell Expansion Market: Competitor Landscape 

In February 2024, AstraZeneca, a global biopharmaceutical company, invested USD 300 million in its Maryland Facility to amplify cell therapy research. The investment will boost the cell therapy capabilities of AstraZeneca, with an initial impetus to critical cancer trials and future commercial supply. With a focus on developing T-cell therapies, the company is expected to create over 150 new jobs in the region. This investment will expand its footprint in cell therapy and novel treatments for various medical conditions. Such investment initiatives spur innovation and development in cell expansion technologies and support market growth.

 

The key features of the cell expansion market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Corning Incorporated
  • Miltenyi Biotec
  • Merck KGaA
  • Becton, Dickinson and Company
  • TERUMO BCT, INC.
  • Takara Bio Inc.
  • Getinge AB
  • Eppendorf AG
  • Promocell GmbH

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Cell Type
  • Application
  • End User
  • Region
Breakup by Product
  • Consumables
  • Media
  • Reagent
  • SERA
  • Disposables
  • Instruments
Breakup by Cell Type
  • Human Cell
  • Animal Cell
Breakup by Application
  • Regenerative Medicine and Stem Cell Research
  • Cancer Research
  • Drug Screening and Development
  • Tissue Engineering
  • Other Applications
Breakup by End User
  • Biotechnology and Biopharmaceutical Companies
  • Research Institutes
  • Cell Banks
  • Other End User
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Corning Incorporated
  • Miltenyi Biotec
  • Merck KGaA
  • Becton, Dickinson and Company
  • TERUMO BCT, INC.
  • Takara Bio Inc.
  • Getinge AB
  • Eppendorf AG
  • Promocell GmbH

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Cell Expansion Market (2017-2032) Overview 

    3.1    Global Cell Expansion Market (2017-2032) Historical Value (2017-2023) 
    3.2    Global Cell Expansion Market (2017-2032) Forecast Value (2024-2032)
4    Global Cell Expansion Market (2017-2032) Landscape
    4.1    Global Cell Expansion Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cell Expansion Product Landscape
        4.2.1    Analysis by Product
        4.2.2    Analysis by Cell Type 
        4.2.3    Analysis by Application
5    Global Cell Expansion Market (2017-2032) Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cell Expansion Market (2017-2032) Segmentation 
    6.1    Global Cell Expansion Market (2017-2032) by Product
        6.1.1    Market Overview
        6.1.2    Consumables
        6.1.3    Media
        6.1.4    Reagent
        6.1.5    SERA
        6.1.6    Disposables
        6.1.7    Instruments
            6.1.7.1    Cell Expansion Supporting Equipment
            6.1.7.2    Bioreactors
        6.1.7.3    Automated Cell Expansion Systems
    6.2    Global Cell Expansion Market (2017-2032) by Cell Type
            6.2.1    Market Overview
            6.2.2    Human Cell
            6.2.3    Animal Cell
    6.3    Global Cell Expansion Market (2017-2032) by Application
            6.3.1    Market Overview
            6.3.2    Regenerative Medicine and Stem Cell Research
            6.3.3    Cancer Research
            6.3.4    Drug Screening and Development
            6.3.5    Tissue Engineering
            6.3.6    Other Applications
    6.4    Global Cell Expansion Market (2017-2032) by End User
            6.4.1    Market Overview
            6.4.2    Biotechnology and Biopharmaceutical Companies
            6.4.3    Research Institutes
            6.4.4    Cell Banks
            6.4.5    Other End User
    6.5    Global Cell Expansion Market (2017-2032) by Region
            6.5.1    Market Overview
            6.5.2    North America 
            6.5.3    Europe
            6.5.4    Asia Pacific
            6.5.5    Latin America
            6.5.6    Middle East and Africa
7    North America Cell Expansion Market (2017-2032)
    7.1    North America Cell Expansion Market (2017-2032) by Product
        7.1.1    Market Overview
        7.1.2    Consumables
        7.1.3    Media
        7.1.4    Reagent
        7.1.5    SERA
        7.1.6    Disposables
        7.1.7    Instruments
            7.1.7.1    Cell Expansion Supporting Equipment
            7.1.7.2    Bioreactors
            7.1.7.3    Automated Cell Expansion Systems.
    7.2    North America Cell Expansion Market (2017-2032) by Cell Type
        7.2.1    Market Overview
        7.2.2    Human Cell
        7.2.3    Animal Cell
    7.3    North Cell Expansion Market (2017-2032) by Country
    7.3.1    United States of America
    7.3.2    Canada
    7.4    Europe Cell Expansion Market (2017-2032) by Product
        7.4.1    Market Overview 
        7.4.2    Consumables
        7.4.3    Media
        7.4.4    Reagent
        7.4.5    SERA
        7.4.6    Disposables
        7.4.7    Instruments
            7.4.7.1    Cell Expansion Supporting Equipment
            7.4.7.2    Bioreactors
            7.4.7.3    Automated Cell Expansion Systems.
    7.5    Europe Cell Expansion Market (2017-2032) by Cell Type
        7.5.1    Market Overview
        7.5.2    Human Cell
        7.5.3    Animal Cell
    7.6    Europe Cell Expansion Market (2017-2032) by Country
        7.6.1    United Kingdom
        7.6.2    Germany
        7.6.3    France
        7.6.4    Italy
        7.6.5    Others
8    Asia Pacific Cell Expansion Market (2017-2032)
    8.1    Asia Pacific Cell Expansion Market (2017-2032) by Product
        8.1.1    Market Overview
        8.1.2    Consumables
        8.1.3    Media
        8.1.4    Reagent
        8.1.5    SERA
        8.1.6    Disposables
        8.1.7    Instruments
            8.1.7.1    Cell Expansion Supporting Equipment
             8.1.7.2    Bioreactors
            8.1.7.3    Automated Cell Expansion Systems.
    8.2    Asia Pacific Cell Expansion Market (2017-2032) by Cell Type
        8.2.1    Market Overview
        8.2.2    Human Cell
        8.2.3    Animal Cell
    8.3    Asia Pacific Cell Expansion Market (2017-2032) by Country
        8.3.1    China
        8.3.2    Japan
        8.3.3    India
        8.3.4    Australia
        8.3.5    ASEAN
        8.3.6    Others
9    Latin America Cell Expansion Market (2017-2032)
    9.1    Latin America Cell Expansion Market (2017-2032) by Product
        9.1.1    Market Overview
        9.1.2    Consumables
        9.1.3    Media
        9.1.4    Reagent
        9.1.5    SERA
        9.1.6    Disposables
        9.1.7    Instruments
            9.1.7.1    Cell Expansion Supporting Equipment
            9.1.7.2    Bioreactors
            9.1.7.3    Automated Cell Expansion Systems.
    9.2    Latin America Cell Expansion Market (2017-2032) by Cell Type
        9.2.1    Market Overview
        9.2.2    Human Cell
        9.2.3    Animal Cell
    9.3    Latin Cell Expansion Market (2017-2032) by Country
        9.3.1    Brazil
        9.3.2    Argentina
        9.3.3    Mexico
        9.3.4    Others
10    Middle East and Africa Cell Expansion Market (2017-2032)
    10.1    Middle East and Africa Cell Expansion Market (2017-2032) by Product
        10.1.1    Market Overview
        10.1.2    Consumables
        10.1.3    Media
        10.1.4    Reagent
        10.1.5    SERA
        10.1.6    Disposables
        10.1.7    Instruments
            10.1.7.1    Cell Expansion Supporting Equipment
            10.1.7.2    Bioreactors
            10.1.7.3    Automated Cell Expansion Systems.
    10.2    Middle East and Africa Cell Expansion Market (2017-2032) by Cell Type
        10.2.1    Market Overview
        10.2.2    Human Cell
        10.2.3    Animal Cell
    10.3    Middle East and Africa Cell Expansion Market (2017-2032) by Country
        10.3.1    Saudi Arabia
        10.3.2    United Arab Emirates
        10.3.3    Nigeria
        10.3.4    South Africa
        10.3.5    Others
11    Patent Analysis
    11.1    Analysis by Type of Patent
    11.2    Analysis by Publication year
    11.3    Analysis by Issuing Authority
    11.4    Analysis by Patent Age
    11.5    Analysis by CPC Analysis
    11.6    Analysis by Patent Valuation 
    11.7    Analysis by Key Players
12    Grants Analysis
    12.1    Analysis by year
    12.2    Analysis by Amount Awarded
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Grant Application
    12.5    Analysis by Funding Institute
    12.6    Analysis by NIH Departments
    12.7    Analysis by Recipient Organization 
13    Funding and Investment Analysis
    13.1    Analysis by Funding Instances
    13.2    Analysis by Type of Funding
    13.3    Analysis by Funding Amount
    13.4    Analysis by Leading Players
    13.5    Analysis by Leading Investors
    13.6    Analysis by Geography
14    Partnership and Collaborations Analysis
    14.1    Analysis by Partnership Instances
    14.2    Analysis by Type of Partnership
    14.3    Analysis by Leading Players
    14.4    Analysis by Geography
15    Regulatory Framework
16    Supplier Landscape

    16.1    Thermo Fisher Scientific, Inc.
        16.1.1    Financial Analysis
        16.1.2    Product Portfolio
        16.1.3    Demographic Reach and Achievements
        16.1.4    Mergers and Acquisitions
        16.1.5    Certifications
    16.2    GE Healthcare
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisitions
        16.2.5    Certifications
    16.3    Corning Incorporated
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisitions
        16.3.5    Certifications
    16.4    Miltenyi Biotec
        16.4.1    Financial Analysis
        16.4.2    Financial Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisitions
        16.4.5    Certifications
    16.5    Merck KGaA
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisitions
        16.5.5    Certifications
    16.6    Becton, Dickinson and Company
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisitions
        16.6.5    Certifications
    16.7    TERUMO BCT, INC.
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisitions
        16.7.5    Certifications
    16.8    Takara Bio Inc.
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisitions
        16.8.5    Certifications
    16.9    Getinge AB
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisitions
        16.9.5    Certifications
    16.10    Eppendorf AG
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisitions
        16.10.5    Certifications
    16.11    Promocell GmbH
        16.11.1    Financial Analysis
        16.11.2    Product Portfolio
        16.11.3    Demographic Reach and Achievements
        16.11.4    Mergers and Acquisitions
        16.11.5    Certifications
17    Global Cell Expansion Market (2017-2032) Distribution Model (Additional Insight)
    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment 
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.


* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Key Questions Answered in the Report

The market attained a value of about USD 21 billion in 2023 driven by the rising incidence of chronic diseases and intensive research activities for cell-based therapies across the globe.

The market is anticipated to grow at a CAGR of 16.2% during the forecast period of 2024-2032, likely to reach a market value of USD 81 billion by 2032.

The growing geriatric population, and increased healthcare expenditure to provide innovative and enhanced treatment alternatives are fuelling the demand for the cell expansion industry.

Rising automation of cell expansion processes is a major market trend. In January 2024, Multiply Labs, announced performance results for its proof-of-concept robotic system that aims at automating cell therapy manufacturing processes including cell quantity and quality.

Based on the product, the market is segmented into consumables and instruments. Consumables are further divided into media, reagents, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems. 

Based on the cell type, the market is segmented into human cells and animal cells.

Major end users of the cell expansion sector include biotechnology and biopharmaceutical companies, research institutes, and cell banks, among other end users.

Cell expansion finds its application in regenerative medicine and stem cell research, cancer research, drug screening and development, and tissue engineering, among others. 

The major regions of the market include North America, Europe, Asia Pacific, and Latin America, Middle East, and Africa.

Key players involved in the market are Thermo Fisher Scientific, Inc., GE Healthcare, Corning Incorporated, Miltenyi Biotec, Merck KGaA, Becton, Dickinson and Company, TERUMO BCT, INC., TakaraBio Inc., Getinge AB, Eppendorf AG, and Promocell GmbH.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER